[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100357342":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":41,"centralContacts":46,"locations":52,"responsibleParty":219,"collaborators":222,"id":226,"slug":227,"hasResults":228,"nctId":229,"briefTitle":230,"officialTitle":231,"acronym":232,"eligibilityCriteria":233,"healthyVolunteers":234,"sex":235,"minAge":10,"maxAge":10,"enrollmentInfo":236,"targetDuration":10,"studyType":239,"phases":10,"briefSummary":240,"conditions":241,"keywords":10,"overallStatus":55,"whyStopped":10,"lastUpdateSubmitDate":247,"lastUpdatePostDateStruct":248,"startDateStruct":251,"completionDateStruct":253,"leadSponsor":255,"locationsCount":256},{"fullName":5,"class":6},"Vanderbilt-Ingram Cancer Center","OTHER",[8,17],{"label":9,"type":10,"description":10,"interventionNames":11},"Retrospective(biospecimens, vision assessment, questionnaires)",null,[12,13,14,15,16],"Procedure: Biospecimen collection","Other: Vision assessment","Other: Questionnaire administration","Other: Quality of life assessment","Other: Laboratory Biomarker Analysis",{"label":18,"type":10,"description":10,"interventionNames":19},"Prospective (biospecimens, vision assessment, questionnaires)",[12,13,14,15,16],[21,26,30,34,37],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":10},"PROCEDURE","Biospecimen collection","Collection of tissue and saliva samples",[18,9],{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":10},"Vision assessment","Undergo vision assessment",[18,9],{"type":6,"name":31,"description":32,"armGroupLabels":33,"otherNames":10},"Questionnaire administration","Complete questionnaires",[18,9],{"type":6,"name":35,"description":32,"armGroupLabels":36,"otherNames":10},"Quality of life assessment",[18,9],{"type":6,"name":38,"description":39,"armGroupLabels":40,"otherNames":10},"Laboratory Biomarker Analysis","Correlative studies",[18,9],[42],{"name":43,"affiliation":44,"role":45},"Debra Friedman, MD","Vanderbilt Medical Center","PRINCIPAL_INVESTIGATOR",[47],{"name":48,"role":49,"phone":50,"phoneExt":10,"email":51},"Vanderbilt-Ingram Service for Timely Access","CONTACT","800-811-8480","cip@vanderbilt.edu",[53,73,85,101,117,133,149,160,176,187,203],{"facility":54,"status":55,"city":56,"state":57,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Lurie Children's Hospital","RECRUITING","Chicago","Illinois","60611","United States","US",{"type":62,"coordinates":63},"Point",[64,65],-87.65005,41.85003,{"lat":65,"lon":64},[68,71],{"name":69,"role":49,"phone":10,"phoneExt":10,"email":70},"Monica Newmark","mnewmark@luriechildrens.org",{"name":72,"role":45,"phone":10,"phoneExt":10,"email":10},"Joanna Weinstein, MD",{"facility":74,"status":55,"city":56,"state":57,"zip":75,"country":59,"countryCode":60,"cosmosGeoPoint":76,"geoPoint":78,"contacts":79},"University of Illinois, Chicago","60612",{"type":62,"coordinates":77},[64,65],{"lat":65,"lon":64},[80,83],{"name":81,"role":49,"phone":10,"phoneExt":10,"email":82},"Kristen kitsch","kitsc@uic.edu",{"name":84,"role":45,"phone":10,"phoneExt":10,"email":10},"Mary Lou Schmidt, MD",{"facility":86,"status":55,"city":87,"state":88,"zip":89,"country":59,"countryCode":60,"cosmosGeoPoint":90,"geoPoint":94,"contacts":95},"University of Minnesoa","Minneapolis","Minnesota","55455",{"type":62,"coordinates":91},[92,93],-93.26384,44.97997,{"lat":93,"lon":92},[96,99],{"name":97,"role":49,"phone":10,"phoneExt":10,"email":98},"Kendra Pallin","palli007@umn.edu",{"name":100,"role":45,"phone":10,"phoneExt":10,"email":10},"Joseph Neglia, MD",{"facility":102,"status":55,"city":103,"state":104,"zip":105,"country":59,"countryCode":60,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"Washington School of Medicine at St. Louis","St Louis","Missouri","63110",{"type":62,"coordinates":107},[108,109],-90.19789,38.62727,{"lat":109,"lon":108},[112,115],{"name":113,"role":49,"phone":10,"phoneExt":10,"email":114},"Kara Sauerburger","sauerburgerk@wustl.edu",{"name":116,"role":45,"phone":10,"phoneExt":10,"email":10},"Robert Hayashi, MD",{"facility":118,"status":55,"city":119,"state":120,"zip":121,"country":59,"countryCode":60,"cosmosGeoPoint":122,"geoPoint":126,"contacts":127},"Cincinnati Children's Hospital Medical Center","Cincinnati","Ohio","45229",{"type":62,"coordinates":123},[124,125],-84.51439,39.12711,{"lat":125,"lon":124},[128,131],{"name":129,"role":49,"phone":10,"phoneExt":10,"email":130},"Amanda Pfeiffer","amanda.pfeiffer@cchmc.org",{"name":132,"role":45,"phone":10,"phoneExt":10,"email":10},"Rajaram Nagarajan, MD",{"facility":134,"status":55,"city":135,"state":136,"zip":137,"country":59,"countryCode":60,"cosmosGeoPoint":138,"geoPoint":142,"contacts":143},"Children's Hospital of Philadelphia","Philadelphia","Pennsylvania","19104",{"type":62,"coordinates":139},[140,141],-75.16362,39.95238,{"lat":141,"lon":140},[144,147],{"name":145,"role":49,"phone":10,"phoneExt":10,"email":146},"Stephen Markham","markhams@chop.edu",{"name":148,"role":45,"phone":10,"phoneExt":10,"email":10},"Amish Shah, MD, PhD",{"facility":5,"status":55,"city":150,"state":151,"zip":152,"country":59,"countryCode":60,"cosmosGeoPoint":153,"geoPoint":157,"contacts":158},"Nashville","Tennessee","37232",{"type":62,"coordinates":154},[155,156],-86.78444,36.16589,{"lat":156,"lon":155},[159],{"name":48,"role":49,"phone":50,"phoneExt":10,"email":10},{"facility":161,"status":55,"city":162,"state":163,"zip":164,"country":59,"countryCode":60,"cosmosGeoPoint":165,"geoPoint":169,"contacts":170},"MD Anderson Cancer Center","Houston","Texas","77030",{"type":62,"coordinates":166},[167,168],-95.36327,29.76328,{"lat":168,"lon":167},[171,174],{"name":172,"role":49,"phone":10,"phoneExt":10,"email":173},"Theresa Honey","TAHoney@mdanderson.org",{"name":175,"role":45,"phone":10,"phoneExt":10,"email":10},"Anna Herzog, MD",{"facility":177,"status":55,"city":162,"state":163,"zip":164,"country":59,"countryCode":60,"cosmosGeoPoint":178,"geoPoint":180,"contacts":181},"Texas Childeren's Hospital",{"type":62,"coordinates":179},[167,168],{"lat":168,"lon":167},[182,185],{"name":183,"role":49,"phone":10,"phoneExt":10,"email":184},"Najeeba Ali","nmali@texaschildrens.org",{"name":186,"role":45,"phone":10,"phoneExt":10,"email":10},"Murali Chintagumpala, MD",{"facility":188,"status":55,"city":189,"state":190,"zip":191,"country":59,"countryCode":60,"cosmosGeoPoint":192,"geoPoint":196,"contacts":197},"Children's Hospital of Wisconsin","Milwaukee","Wisconsin","53226",{"type":62,"coordinates":193},[194,195],-87.90647,43.0389,{"lat":195,"lon":194},[198,201],{"name":199,"role":49,"phone":10,"phoneExt":10,"email":200},"Veronica Seher","vseher@mcw.edu",{"name":202,"role":45,"phone":10,"phoneExt":10,"email":10},"Cindy Schwartz, MD",{"facility":204,"status":55,"city":205,"state":10,"zip":10,"country":206,"countryCode":207,"cosmosGeoPoint":208,"geoPoint":212,"contacts":213},"The Hosptial for Sick Children","Toronto","Canada","CA",{"type":62,"coordinates":209},[210,211],-79.39864,43.70643,{"lat":211,"lon":210},[214,217],{"name":215,"role":49,"phone":10,"phoneExt":10,"email":216},"Roxanna Noronha","roxanna.noronha@sickkids.ca",{"name":218,"role":45,"phone":10,"phoneExt":10,"email":10},"Helen Dimaras, MD",{"type":45,"investigatorFullName":220,"investigatorTitle":221,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Debra Friedman","Sponsor Investigator",[223],{"name":224,"class":225},"National Cancer Institute (NCI)","NIH","100357342","studying-health-outcomes-after-treatment-in-patients-with-retinoblastoma-100357342",false,"NCT03932786","Studying Health Outcomes After Treatment in Patients With Retinoblastoma","Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)","RIVERBOAT","* Unilateral or bilateral intraocular retinoblastoma\n* Diagnosis between the ages of 0 - 17.99 years\n* Diagnosis on or after January 1, 2008\n* No exclusions based on primary or secondary treatment modalities\n* Retrospective group patients must be ≥ 6 months post end of treatment at study entry\n\n  * For those already at this timepoint, they are now eligible\n  * For those in treatment, or otherwise not yet at this timepoint, they are eligible once at they are ≥ 6 months post end of treatment\n  * Prospective group patients must not have begun treatment\n* Patients with diminished capacity will not be enrolled.\n* Language: Patients must be able to communicate in English, French, or Spanish\n* Sibling Cohort: One sibling, not affected by retinoblastoma will be enrolled, preference for the sibling closest in age to the RB patient.\n* Regulatory Requirements: All patients and\u002For their parents or legal guardians must sign a written informed consent. All institutional, FDA, and NCI requirements for human studies must be met.",true,"ALL",{"count":237,"type":238},900,"ESTIMATED","OBSERVATIONAL","This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma",[242,243,244,245,246],"Retinoblastoma","Cancer Survivor","Biological Sibling","Intraocular Retinoblastoma","Unilateral Retinoblastoma","2025-09-15",{"date":249,"type":250},"2025-09-19","ACTUAL",{"date":252,"type":250},"2019-01-24",{"date":254,"type":238},"2031-01",{"name":5,"class":6},11]